| Antigen | 19-aa peptide of Human KCC3 ; (Gene Accession #NP005126.1) Designated (KCC31-P or control peptide or blocking peptide) conjugated to KLH; epitope location ~ N-terminal, Cytoplasmic domain |
| Form | Affinity purified IgG |
| Product Type | Primary Antibodies |
| SpCrossreactivity | Human KCC31-P antigenic peptide sequence is found in one of the alternatively spliced form (KCC-3b). KCC31-P is 89% conserved in rat and 78% in mouse KCC-3b. The other form of the human KCC3a (1150 aa; Mount DB et al 1999) does not share this sequence. We have raised another antibody (cat # KCC32-S) using the C-terminal peptide sequence that is found in both forms of KCC3. KCC31-P has no significant sequence homology with other KCCs or CCC. Antibody crossreactivity in various species is not established |
| SpeciesReactivity | Human |
| SugApplications | Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the |
| SugNegativeControl | Non-immune Rabbit IgG Cat# 20009-1 |
| SugPositiveControl | Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid |
| SugSecAntibodies | http://4adi.com/commerce/ccc2480-secondary-antibodies-rabbit.htm |